Nissan North America, Inc.
Summary
NHTSA campaign 22V666: Nissan North America, Inc. recalled for a safety defect. Seat belts that do not retract properly may be difficult to operate, preventing their usage, which can increase the risk
Details
Source
nhtsa
External ID
22V666
Action Date
2022-09-07
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2021-2022 Rogue vehicles. The rear seat belts for the left-hand and right-hand rear seats may not retract properly. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard numbers 208, "Occupant Crash Protection," and 209, "Seatbelt Assemblies."
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle